A semi-rational design strategy of directed evolution combined with chemical synthesis of DNA sequences.
Directed evolution in vitro is a powerful molecular tool for the creation of new biological phenotypes. It is unclear whether it is more efficient to mutate an enzyme randomly or to mutate just the active sites or key sites. In this study, the strategy of a semi-rational design of directed evolution combined with whole sequence and sites was developed. The 1553 bp gene encoding the thermostable beta-galactosidase of Pyrococcus woesei was chemically synthesized and optimized for G+C content and mRNA secondary structures. The synthesized gene product was used as a template or as a wild-type control. On the basis of the first round of DNA shuffling, library construction and screening, one mutant of YH6754 was isolated with higher activity. Eight potential key sites were deduced from the sequence of the shuffled gene, and 16 degenerate oligonucleotides were designed according to those eight amino acids. Two variants of YG6765 and YG8252 were screened in the second part of DNA shuffling, library construction and screening. For comparison, one mutant of YH8757 was screened through the same routine rounds of directed evolution with YH6754 as template. The purified beta-galactosidase from YH8757 exhibited a lower specific activity at 25 degrees C than those purified from mutated YG6755 and YG8252.
Xiong
Ai-Sheng
AS
Biotechnology Research Institute of Shanghai Academy of Agricultural Sciences, 2901 Beidi Road, Shanghai 201106, China.
Peng
Ri-He
RH
Zhuang
Jing
J
Liu
Jin-Ge
JG
Gao
Feng
F
Xu
Fang
F
Cai
Bin
B
Yao
Quan-Hong
QH
D003062:Codon; D004247:DNA / Q000138:chemical synthesis*; D032621:DNA Shuffling; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D019020:Directed Molecular Evolution / Q000379:methods*; D015195:Drug Design; D004926:Escherichia coli / Q000201:enzymology / Q000378:metabolism; D007700:Kinetics; D008958:Models, Molecular; D009154:Mutation / Q000235:genetics / Q000502:physiology; D009841:Oligonucleotides / Q000138:chemical synthesis / Q000737:chemistry; D011487:Protein Conformation; D019711:Pyrococcus / Q000201:enzymology / Q000378:metabolism; D012343:RNA, Transfer / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D001616:beta-Galactosidase / Q000096:biosynthesis / Q000737:chemistry / Q000302:isolation & purification
D003062:Codon; D004273:DNA, Neoplasm; D009841:Oligonucleotides; D004247:DNA; D012343:RNA, Transfer; D001616:beta-Galactosidase